NEW
Crysvita

Crysvita Patient Counseling Information

Manufacturer:

Kyowa Kirin

Distributor:

DCH Auriga - Healthcare
Full Prescribing Info
Patient Counseling Information
Drug Interactions: Advise patients not to use any oral phosphate and/or active vitamin D analog products [see Contraindications].
Hypersensitivity Reactions: Advise patients that CRYSVITA may cause hypersensitivity events such as rash, injection site rash and urticaria. Instruct the patients to contact their physician if such reactions occur [see Clinical Trials Experience under Adverse Reactions].
Injection Site Reactions: Inform patients that injection site reactions (e.g. erythema, rash, swelling, bruising, pain, pruritus, urticaria, and hematoma) have occurred at the site of CRYSVITA injection. Instruct the patients to contact their physician if such reactions occur [see Clinical Trials Experience under Adverse Reactions].
Restless Leg Syndrome: Advise patients that CRYSVITA can induce RLS or worsen the symptoms of existing RLS. Instruct the patients to contact their physician if such a reaction occurs [see Clinical Trials Experience under Adverse Reactions].
Pregnancy: [See Pregnancy under Use in Pregnancy & Lactation.]
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in